semaglutide patent novo nordisk Ozempic's problem: how lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo Nordisk Braces as Generic

Colleen H

These procedures offer the chance to create healthier eating habits and lifestyle changestheyre more than a quick fix like GLP-1 medications

That is approximately how much it would have cost Novo Nordisk a company that generated over $12 billion in GLP-1 revenues in a single year to maintain its primary semaglutide patent in Canada

BOCA RATON, Fla., May 5, 2026 /PRNewswire/ -- MyNetDiary, the top-rated calorie counter and nutrition tracking app with 31 million registered users, today launched GLP-1 Companion within its Premium tier

Brief Introduction to Sermorelin and Semaglutide Distinct ways of work feature these drugs